PRH In the News
OBGYN: Judge’s order banning abortion pill is the ‘beginning of the assault’
President & CEO Dr. Jamila Perritt discusses the impact on women’s healthcare of the Texas judge’s ruling and what’s next in the legal fight.
Archive: PRH in the News
PRH In the News
Federal judge bans abortion pill: What the ruling means for women across the country
Fellows Ashley Jeanlus & Gopika Krishna share how the ruling on mifepristone by a Texas district judge may impact women.
PRH In the News
Texas Judge’s Mifepristone Ruling Questioned by Doctors
Our Fellow Smita Carroll comments on the ruling by a Texas district judge attempting to stay the FDA’s approval of mifepristone, America’s most commonly-used abortion […]
PRH In the News
Texas court blocks preventative care coverage for HIV, reproductive health
President & CEO Dr. Jamila Perritt speaks out against a Texas court decision that blocks preventative care coverage.
PRH In the News
What fighting for access to reproductive healthcare looks like in 2023
Our Fellow Dr. Mollie Nisen based in Washington state shares how the uptick in out-of-state demand for reproductive healthcare impacts both doctors and patients.
PRH In the News
These Seven States Are Sleepwalking Into a Maternal Mortality Crisis
Our Fellow Smita Carroll spoke to Newsweek about how carrying a pregnancy to term has more risks than abortion care.
PRH In the News
There is no such thing as abortion “reversal”
Our Fellow Michael Belmonte writes about how the dangerous ideology of abortion “reversal” should not be part of medical practice or public policy.
PRH In the News
What is mifepristone, the drug at the heart of the Texas medication abortion lawsuit?
Our Fellow Melissa Wong spoke to CNN about the differences between Misoprostol and Mifeprestone, two safe and common abortion medications often used in combination.